In the final multiple logistic regression, higher odds of having CD73 expression were found in female patients (OR = 2.74, 95% CI 1.07–7.01), those with higher level of primary tumor (T2: OR = 6.59, 95% CI 1.36–31.90; T4: OR = 9.13, 95% CI 1.68–49.66) and those with mucoepidermoid carcinoma (OR = 10.62, 95% CI 2.77–40.69). The gene discussed is NT5E; the disease is mucoepidermoid carcinoma.